LEGN logo

Legend Biotech (LEGN) Cash from operations

annual CFO:

-$144.03M+$249.24M(+63.38%)
December 31, 2024

Summary

  • As of today (June 28, 2025), LEGN annual cash flow from operations is -$144.03 million, with the most recent change of +$249.24 million (+63.38%) on December 31, 2024.
  • During the last 3 years, LEGN annual CFO has risen by +$54.43 million (+27.43%).
  • LEGN annual CFO is now -146.81% below its all-time high of $307.68 million, reached on December 31, 2018.

Performance

LEGN Cash from operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLEGNcash flow metrics

quarterly CFO:

-$103.75M-$21.68M(-26.41%)
March 31, 2025

Summary

  • As of today (June 28, 2025), LEGN quarterly cash flow from operations is -$103.75 million, with the most recent change of -$21.68 million (-26.41%) on March 31, 2025.
  • Over the past year, LEGN quarterly CFO has dropped by -$119.27 million (-768.60%).
  • LEGN quarterly CFO is now -620.15% below its all-time high of $19.95 million, reached on September 30, 2019.

Performance

LEGN quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLEGNcash flow metrics

TTM CFO:

-$263.31M-$119.27M(-82.81%)
March 31, 2025

Summary

  • As of today (June 28, 2025), LEGN TTM cash flow from operations is -$263.31 million, with the most recent change of -$119.27 million (-82.81%) on March 31, 2025.
  • Over the past year, LEGN TTM CFO has dropped by -$24.76 million (-10.38%).
  • LEGN TTM CFO is now -6082.32% below its all-time high of -$4.26 million, reached on March 31, 2019.

Performance

LEGN TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLEGNcash flow metrics

Cash from operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

LEGN Cash from operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+63.4%-768.6%-10.4%
3 y3 years+27.4%-31.9%-5.2%
5 y5 years-73.4%-126.6%-111.3%

LEGN Cash from operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+63.4%-768.6%+25.5%-84.6%+33.0%
5 y5-year-73.4%+63.4%-768.6%+25.5%-111.3%+33.0%
alltimeall time-146.8%+63.4%-620.1%+25.5%-6082.3%+33.0%

LEGN Cash from operations History

DateAnnualQuarterlyTTM
Mar 2025
-
-$103.75M(+26.4%)
-$263.31M(+82.8%)
Dec 2024
-$144.03M(-63.4%)
-$82.08M(+8.3%)
-$144.03M(-8.6%)
Sep 2024
-
-$75.82M(+4492.5%)
-$157.60M(+10.5%)
Jun 2024
-
-$1.65M(-110.6%)
-$142.63M(-40.2%)
Mar 2024
-
$15.52M(-116.2%)
-$238.54M(-39.3%)
Dec 2023
-$393.28M(+95.4%)
-$95.64M(+57.2%)
-$393.28M(+13.2%)
Sep 2023
-
-$60.85M(-37.6%)
-$347.37M(-3.1%)
Jun 2023
-
-$97.57M(-29.9%)
-$358.64M(+37.0%)
Mar 2023
-
-$139.22M(+179.9%)
-$261.81M(+30.1%)
Dec 2022
-$201.28M(+1.4%)
-$49.74M(-31.0%)
-$201.28M(-9.0%)
Sep 2022
-
-$72.11M(+9644.9%)
-$221.09M(+14.2%)
Jun 2022
-
-$740.00K(-99.1%)
-$193.57M(-22.7%)
Mar 2022
-
-$78.69M(+13.1%)
-$250.37M(+26.2%)
DateAnnualQuarterlyTTM
Dec 2021
-$198.47M(-11.0%)
-$69.55M(+56.0%)
-$198.47M(+7.4%)
Sep 2021
-
-$44.59M(-22.5%)
-$184.87M(-9.7%)
Jun 2021
-
-$57.54M(+114.8%)
-$204.65M(+0.3%)
Mar 2021
-
-$26.79M(-52.1%)
-$204.00M(-8.5%)
Dec 2020
-$223.00M(+168.5%)
-$55.95M(-13.1%)
-$223.00M(-1.8%)
Sep 2020
-
-$64.37M(+13.2%)
-$227.04M(+59.1%)
Jun 2020
-
-$56.88M(+24.2%)
-$142.72M(+14.5%)
Mar 2020
-
-$45.80M(-23.7%)
-$124.60M(+50.0%)
Dec 2019
-$83.06M(-127.0%)
-$59.99M(-400.7%)
-$83.06M(+259.9%)
Sep 2019
-
$19.95M(-151.5%)
-$23.08M(-46.4%)
Jun 2019
-
-$38.77M(+810.2%)
-$43.02M(+910.2%)
Mar 2019
-
-$4.26M
-$4.26M
Dec 2018
$307.68M
-
-

FAQ

  • What is Legend Biotech annual cash flow from operations?
  • What is the all time high annual CFO for Legend Biotech?
  • What is Legend Biotech annual CFO year-on-year change?
  • What is Legend Biotech quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Legend Biotech?
  • What is Legend Biotech quarterly CFO year-on-year change?
  • What is Legend Biotech TTM cash flow from operations?
  • What is the all time high TTM CFO for Legend Biotech?
  • What is Legend Biotech TTM CFO year-on-year change?

What is Legend Biotech annual cash flow from operations?

The current annual CFO of LEGN is -$144.03M

What is the all time high annual CFO for Legend Biotech?

Legend Biotech all-time high annual cash flow from operations is $307.68M

What is Legend Biotech annual CFO year-on-year change?

Over the past year, LEGN annual cash flow from operations has changed by +$249.24M (+63.38%)

What is Legend Biotech quarterly cash flow from operations?

The current quarterly CFO of LEGN is -$103.75M

What is the all time high quarterly CFO for Legend Biotech?

Legend Biotech all-time high quarterly cash flow from operations is $19.95M

What is Legend Biotech quarterly CFO year-on-year change?

Over the past year, LEGN quarterly cash flow from operations has changed by -$119.27M (-768.60%)

What is Legend Biotech TTM cash flow from operations?

The current TTM CFO of LEGN is -$263.31M

What is the all time high TTM CFO for Legend Biotech?

Legend Biotech all-time high TTM cash flow from operations is -$4.26M

What is Legend Biotech TTM CFO year-on-year change?

Over the past year, LEGN TTM cash flow from operations has changed by -$24.76M (-10.38%)
On this page